Curative Biosciences Stock Today
| CBDX Stock | USD 0.0001 0.00 0.00% |
PerformanceVery Weak
| Odds Of DistressVery High
|
Curative Biosciences is trading at 1.0E-4 as of the 20th of March 2025; that is No Change since the beginning of the trading day. The stock's open price was 1.0E-4. Curative Biosciences has a very high chance of experiencing financial distress in the next few years of operation. It has also generated negative returns for investors over the last 90 days. The performance scores are derived for the period starting the 20th of December 2024 and ending today, the 20th of March 2025. Click here to learn more.
Curative Biosciences, Inc. focuses on developing and commercializing therapeutics using hemp-derived Cannabidiol. Curative Biosciences, Inc. was founded in 2009 and is based in Miami, Florida. Curative Biosciences is traded on OTC Exchange in the United States. The company has 31.57 M outstanding shares. More on Curative Biosciences
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Curative Pink Sheet Highlights
| CEO, Director | Richard Damion |
| Old Names | [The Medical Cannabis and Wellness UCITS ETF - Accumulating, The Medical Cannabis and Wellness UCITS ETF - Accumulating CHF] |
| Business Concentration | Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Curative Biosciences [CBDX] is a Pink Sheet which is traded between brokers over the counter. The company currently falls under 'Micro-Cap' category with a current market capitalization of 10.56 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Curative Biosciences's market, we take the total number of its shares issued and multiply it by Curative Biosciences's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Curative Biosciences conducts business under Healthcare sector and is part of Drug Manufacturers—Specialty & Generic industry. The entity has 31.57 M outstanding shares.
Curative Biosciences currently holds about 982 in cash with (12.8 K) of positive cash flow from operations.
Check Curative Biosciences Probability Of Bankruptcy
Ownership AllocationCurative Biosciences holds a total of 31.57 Million outstanding shares. Curative Biosciences shows majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 76.24 percent of Curative Biosciences outstanding shares that are owned by insiders signifies that they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Curative Ownership Details
Curative Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Curative Biosciences without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Insider Screener Now
Insider ScreenerFind insiders across different sectors to evaluate their impact on performance |
| All Next | Launch Module |
Additional Tools for Curative Pink Sheet Analysis
When running Curative Biosciences' price analysis, check to measure Curative Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Curative Biosciences is operating at the current time. Most of Curative Biosciences' value examination focuses on studying past and present price action to predict the probability of Curative Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Curative Biosciences' price. Additionally, you may evaluate how the addition of Curative Biosciences to your portfolios can decrease your overall portfolio volatility.